BIOMAT Database Logo BIOMAT Database Logo

Amikacin monotherapy for sepsis caused by panresistant Pseudomonas aeruginosa. 2010

Brice Layeux, and Fabio Silvio Taccone, and David Fagnoul, and Jean-Louis Vincent, and Frédérique Jacobs
Department of Infectious Diseases, Erasme University Hospital, Université Libre de Bruxelles, Route de Lennik 808, Brussels, Belgium.

Two patients with severe sepsis due to panresistant Pseudomonas aeruginosa, deteriorating despite therapy with colistin and β-lactams, were cured with a high daily dose (25 to 50 mg/kg) of amikacin to obtain a peak/MIC ratio of at least 8 to 10 (MIC = 16 μg/ml). Concomitant use of continuous venovenous hemodiafiltration (CVVHDF) provided no deterioration in renal function after treatment. High dosage of aminoglycosides combined with CVVHDF may represent a valuable therapeutic option for infection due to multiresistant pathogens.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000583 Amikacin A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics. A.M.K,Amikacin Sulfate,Amikacina Medical,Amikacina Normon,Amikafur,Amikalem,Amikason's,Amikayect,Amikin,Amiklin,Amukin,BB-K 8,BB-K8,Biclin,Biklin,Gamikal,Kanbine,Oprad,Yectamid,BB K 8,BB K8,BBK 8,BBK8,Medical, Amikacina,Normon, Amikacina,Sulfate, Amikacin
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

Brice Layeux, and Fabio Silvio Taccone, and David Fagnoul, and Jean-Louis Vincent, and Frédérique Jacobs
[Monotherapy or synergic treatment for sepsis caused by Pseudomonas aeruginosa].
January 2003, Pneumonologia i alergologia polska,
Brice Layeux, and Fabio Silvio Taccone, and David Fagnoul, and Jean-Louis Vincent, and Frédérique Jacobs
[Pseudomonas aeruginosa sepsis caused by an intravenous catheter and successfully treated with amikacin].
January 1979, Revista cubana de medicina tropical,
Brice Layeux, and Fabio Silvio Taccone, and David Fagnoul, and Jean-Louis Vincent, and Frédérique Jacobs
Subcutaneous nodules caused by Pseudomonas aeruginosa without sepsis.
March 1999, Cutis,
Brice Layeux, and Fabio Silvio Taccone, and David Fagnoul, and Jean-Louis Vincent, and Frédérique Jacobs
[Neonatal sepsis caused by Pseudomonas aeruginosa (Bacillus pyocyaneus)].
June 1960, Maandschrift voor kindergeneeskunde,
Brice Layeux, and Fabio Silvio Taccone, and David Fagnoul, and Jean-Louis Vincent, and Frédérique Jacobs
New markers for sepsis caused by Pseudomonas aeruginosa during burn infection.
March 2020, Metabolomics : Official journal of the Metabolomic Society,
Brice Layeux, and Fabio Silvio Taccone, and David Fagnoul, and Jean-Louis Vincent, and Frédérique Jacobs
Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
July 2011, American journal of respiratory and critical care medicine,
Brice Layeux, and Fabio Silvio Taccone, and David Fagnoul, and Jean-Louis Vincent, and Frédérique Jacobs
[Sepsis by Pseudomonas aeruginosa].
January 1999, Ryoikibetsu shokogun shirizu,
Brice Layeux, and Fabio Silvio Taccone, and David Fagnoul, and Jean-Louis Vincent, and Frédérique Jacobs
n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa.
December 2004, Antimicrobial agents and chemotherapy,
Brice Layeux, and Fabio Silvio Taccone, and David Fagnoul, and Jean-Louis Vincent, and Frédérique Jacobs
Cefoxitin, amikacin, and Pseudomonas aeruginosa resistance.
September 1982, Lancet (London, England),
Brice Layeux, and Fabio Silvio Taccone, and David Fagnoul, and Jean-Louis Vincent, and Frédérique Jacobs
[The use of amikacin in the treatment of endometritis caused by Pseudomonas aeruginosa in mares].
June 1982, Journal of the South African Veterinary Association,
Copied contents to your clipboard!